FOLR1 and neoplasm: It is known that the expression of FRα is highly correlated with tumor grade, stage, malignancy and aggressiveness (Bueno et al., 2001; Hartmann et al., 2007), therefore suggesting that FRα is a promising target for tumor therapy and diagnosis.